The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Four Brokers Raise Close Brothers Price Target

Wed, 12th Mar 2014 10:05

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
BERENBERG CUTS TRAVIS PERKINS PRICE TARGET TO 1800 (1880) PENCE - 'HOLD'
----------
JEFFERIES CUTS LAND SECURITIES TO 'HOLD' ('BUY') - PRICE TARGET 1112 PENCE
----------
JEFFERIES CUTS BRITISH LAND TO 'HOLD' ('BUY')
----------
BERNSTEIN CUTS MORRISON PRICE TARGET TO 220 (270) PENCE - 'MARKET-PERFORM'
----------
CITIGROUP RAISES ASHTEAD GROUP PRICE TARGET TO 1075 (850) PENCE - 'BUY'
----------
GOLDMAN CUTS PERSIMMON TO 'BUY' ('CONVICTION BUY LIST')
----------
MORGAN STANLEY RAISES SHELL PRICE TARGET TO 2500 (2330) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES BP PRICE TARGET TO 525 (490) PENCE - 'EQUAL-WEIGHT'
----------
GOLDMAN RAISES SPORTS DIRECT PRICE TARGET TO 1100 (980) PENCE - 'CL BUY'
----------
CHARLES STANLEY CUTS ADMIRAL GROUP TO 'REDUCE' ('HOLD')
----------
FTSE 250
----------
BERENBERG RAISES CLOSE BROTHERS PRICE TARGET TO 1640 (1330) PENCE - 'BUY'
----------
NUMIS RAISES CLOSE BROTHERS PRICE TARGET TO 1325 (1214) PENCE - 'HOLD'
----------
JPMORGAN RAISES CLOSE BROTHERS PRICE TARGET TO 1480 (1357) PENCE - 'OVERWEIGHT'
----------
UBS RAISES CLOSE BROTHERS PRICE TARGET TO 1420 (1340) PENCE - 'NEUTRAL'
----------
UBS CUTS FENNER PRICE TARGET TO 480 (500) PENCE - 'BUY'
----------
JEFFERIES CUTS FENNER PRICE TARGET TO 490 (505) PENCE - 'BUY'
----------
UBS RAISES KAZAKHMYS PRICE TARGET TO 300 (210) PENCE - 'NEUTRAL'
----------
UBS CUTS N BROWN TO 'SELL' ('NEUTRAL') - TARGET 535 (565) PENCE
----------
UBS CUTS PREMIER FARNELL PRICE TARGET TO 235 (240) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RIGHTMOVE TO 'BUY' ('CONVICTION BUY LIST')
----------
GOLDMAN CUTS BARRATT DEVELOPMENTS TO 'NEUTRAL' ('BUY')
----------
GOLDMAN RAISES REDROW TO 'BUY' ('NEUTRAL')
----------
DEUTSCHE BANK CUTS GO-AHEAD GROUP TO 'HOLD' ('BUY') - TARGET 2100 (1640) PENCE
----------
DEUTSCHE BANK RAISES ESURE GROUP PRICE TARGET TO 313 (300) PENCE - 'BUY'
----------
CANACCORD CUTS ESURE GROUP PRICE TARGET TO 295 (305) PENCE - 'BUY'
----------
CITIGROUP RAISES ESURE GROUP PRICE TARGET TO 294 (291) PENCE - 'BUY'
----------
NOMURA RAISES INCHCAPE PRICE TARGET TO 600 (580) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK RAISES INCHCAPE PRICE TARGET TO 685 (655) PENCE - 'BUY'
----------
INVESTEC CUTS HUNTING TO 'HOLD' ('BUY')
----------
JPMORGAN RAISES MERLIN PRICE TARGET TO 430 (415) PENCE - 'OVERWEIGHT'
----------
JEFFERIES RAISES CAPITAL & COUNTIES PRICE TARGET TO 362 (294) PENCE - 'HOLD'
----------
GOLDMAN RAISES CREST NICHOLSON TO 'CONVICTION BUY LIST' ('BUY')
----------
GOLDMAN RAISES BOVIS HOMES PRICE TARGET TO 1187 (1070) PENCE - 'BUY'
----------
GOLDMAN CUTS SAVILLS PRICE TARGET TO 719 (771) PENCE - 'NEUTRAL'
----------
PANMURE CUTS HIKMA PHARMACEUTICALS TO 'HOLD' ('BUY') - TARGET 1400 (1375) PENCE
----------
MAIN MARKET AND AIM
----------
GOLDMAN RAISES LSL PROPERTY SERVICES PRICE TARGET TO 642 (626) PENCE - 'BUY'
----------
CANACCORD CUTS ROCKHOPPER EXPLORATION PRICE TARGET TO 265 (345) PENCE - 'BUY'
----------
CANACCORD CUTS BROOKS MACDONALD TO 'HOLD' ('BUY') - TARGET 1780 (1620) PENCE
----------
NUMIS RAISES TYMAN PRICE TARGET TO 320 (285) PENCE - 'ADD'
----------
CANACCORD RAISES CAPE PLC PRICE TARGET TO 360 (300) PENCE - 'BUY'
----------
NUMIS CUTS MODERN WATER PRICE TARGET TO 62 (77) PENCE - 'BUY'
----------
PANMURE RAISES PHOENIX IT TO 'BUY' ('HOLD') - TARGET 136 (144) PENCE
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.